Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,340
Closed -$606K 133
2024
Q3
$606K Sell
5,340
-3,502
-40% -$416K 0.19% 75
2024
Q2
$1.09M Sell
8,842
-2,440
-22% -$314K 0.3% 54
2024
Q1
$1.49M Sell
11,282
-775
-6% -$95.5K 0.42% 49
2023
Q4
$1.31M Sell
12,057
-893
-7% -$92.7K 0.41% 49
2023
Q3
$1.33M Buy
12,950
+2,094
+19% +$226K 0.47% 40
2023
Q2
$1.25M Buy
10,856
+2,471
+29% +$281K 0.46% 43
2023
Q1
$892K Buy
8,385
+6,532
+353% +$705K 0.36% 50
2022
Q4
$206K Buy
+1,853
New +$189K 0.1% 141

Other funds holding MRK

Financial Insights's MRK Position: Q4 2024 in Review

Financial Insights sold out of Merck (MRK) in Q4 2024, closing a stake of 5,340 shares — an estimated $606K sold.

Financial Insights first reported a position in MRK in Q4 2022 and held it in 8 quarters. The position peaked at $1.49M in Q1 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Financial Insights reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Financial Insights sold 5,340 Merck shares in Q4 2024, an estimated $606K.
  • Financial Insights first reported a position in Merck in Q4 2022 and held it in 8 quarters.
  • Financial Insights's Merck position peaked at $1.49M in Q1 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Financial Insights's 13F filing for Q4 2024, filed 5 Mar 2025.